Vaccines for Cancer Immunotherapy

Produk Detail:
  • Author : Nima Rezaei
  • Publisher : Academic Press
  • Pages : 198 pages
  • ISBN : 0128140402
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Vaccines for Cancer Immunotherapy

Download or Read online Vaccines for Cancer Immunotherapy full in PDF, ePub and kindle. this book written by Nima Rezaei and published by Academic Press which was released on 17 October 2018 with total page 198 pages. We cannot guarantee that Vaccines for Cancer Immunotherapy book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the strategy of allogeneic and autologous cancer vaccines, personalized vaccines, whole-tumor antigen vaccines, protein and peptide vaccines, dendritic cell vaccines, genetic vaccines, candidate cancers for vaccination, obstacles to developing therapeutic cancer vaccines, combination therapy, future perspectives and concluding remarks on therapeutic cancer vaccines. Introduces the feasible immunotherapeutic vaccines for patients with different types of cancer Presents the status of past and current vaccines for cancer treatment Considers advantages and disadvantages of different therapeutic cancer vaccines Looks at the combination of vaccines and other modalities, including immunotherapeutic and conventional methods Analyzes obstacles to development of therapeutic cancer vaccines Gives a view on future perspectives in the application of therapeutic cancer vaccines

Vaccines for Cancer Immunotherapy

Vaccines for Cancer Immunotherapy
  • Author : Nima Rezaei,Mahsa Keshavarz-Fathi
  • Publisher : Academic Press
  • Release : 17 October 2018
GET THIS BOOK Vaccines for Cancer Immunotherapy

Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the

Carbohydrate Based Vaccines and Immunotherapies

Carbohydrate Based Vaccines and Immunotherapies
  • Author : Zhongwu Guo,Geert-Jan Boons
  • Publisher : John Wiley & Sons
  • Release : 17 June 2009
GET THIS BOOK Carbohydrate Based Vaccines and Immunotherapies

The fundamental science and the latest developments in carbohydrate-based vaccines The relatively new field of glycoimmunology has emerged from the marriage of glycobiology and immunology, in recognition of the important role carbohydrates play as antigenic determinants. Carbohydrate-Based Vaccines and Immunotherapies comprehensively reviews the state of this exciting field, offering a single source for both the fundamental science and the latest developments. With contributions by leading experts, this resource covers the design, synthesis, evaluation, and applications of various carbohydrate-based vaccines, including

Cancer Immunotherapy

Cancer Immunotherapy
  • Author : Claire Hearnden,Ed C. Lavelle
  • Publisher : Elsevier Inc. Chapters
  • Release : 04 June 2013
GET THIS BOOK Cancer Immunotherapy

This chapter describes the types of adjuvants that are being investigated as potential cancer adjuvant candidates and those that are currently being used in vaccines against certain cancers.

Cancer Immunotherapy

Cancer Immunotherapy
  • Author : Gabriela R. Rossi,Nicholas N. Vahanian,W. Jay Ramsey,Charles J. Link
  • Publisher : Elsevier Inc. Chapters
  • Release : 04 June 2013
GET THIS BOOK Cancer Immunotherapy

The hyperacute rejection of a xenotransplant is characterized by a complement-antibody mediated immune response dependent on αGal epitopes. Animal studies confirm that αGal epitopes expressed on allogeneic tumor vaccines elicit a potent T-cell-dependent antitumor immunity. Based on these immunologic reactions, we hypothesized that the hyperacute rejection mechanism could be exploited to alter antigen processing resulting in a novel therapeutic approach to treat human malignancies. Clinical trials data confirm that an immediate hypersensitivity response directed toward a vaccine composed of genetically

Cancer Immunotherapy

Cancer Immunotherapy
  • Author : Nicholas M. Durham,Charles G. Drake
  • Publisher : Elsevier Inc. Chapters
  • Release : 04 June 2013
GET THIS BOOK Cancer Immunotherapy

The idea of a preventive vaccine against cancer has been extremely attractive because of the immune system’s ability to develop specific and long-lasting immunological memory. Dendritic cells, which present antigen to T cells, sit at a critical point in the activation of the immune system because they are able to activate both B cells and T cells. The first DC vaccines were tested in humans in 1998. In 2010 the first DC vaccine was FDA approved for treatment of patients with

Cancer Immunotherapy

Cancer Immunotherapy
  • Author : Freda K. Stevenson,Gianfranco di Genova,Christian H. Ottensmeier,Natalia Savelyeva
  • Publisher : Elsevier Inc. Chapters
  • Release : 04 June 2013
GET THIS BOOK Cancer Immunotherapy

The goal of mobilizing the immune response against cancer in patients is ambitious, and, to even approach success, all the tools of modern genetics have been required. Tools are needed for three tasks: to profile cancer cells, to understand how they survive and proliferate, and to activate immune pathways able to circumvent tumor protective mechanisms and mediate successful attack. Gene-based vaccines incorporate tumor antigen sequences together with genes encoding molecules identified as critical for inducing responses. The vaccine backbones activate

Cancer Immunotherapy

Cancer Immunotherapy
  • Author : Jeffrey Schlom,James W. Hodge,Claudia Palena,John W. Greiner,Kwong-Yok Tsang,Benedetto Farsaci,Ravi A. Madan,James L. Gulley
  • Publisher : Elsevier Inc. Chapters
  • Release : 04 June 2013
GET THIS BOOK Cancer Immunotherapy

This article reviews progress made in the design and development of recombinant poxviral-based vaccines that express transgenes for tumor-associated antigens (TAAs) and human T-cell co-stimulatory molecules (designated TRICOM). The TRICOM vaccine platform consists of priming with a recombinant vaccinia (rV-) vector and multiple boosts with a replication defective fowlpox (rF-) vector. The rV, rF-PSA-TRICOM (PROSTVAC) has demonstrated survival benefit in randomized trials. rV, rF-CEA-MUC1-TRICOM (PANVAC) has demonstrated evidence of benefit in patients with colorectal, breast and ovarian cancers. Preclinical

Antigen Presenting Cell Tumour Cell Hybrid Vaccines in Cancer Immunotherapy

Antigen Presenting Cell Tumour Cell Hybrid Vaccines in Cancer Immunotherapy
  • Author : Yehia S. Mohamed
  • Publisher : Unknown
  • Release : 27 September 2021
GET THIS BOOK Antigen Presenting Cell Tumour Cell Hybrid Vaccines in Cancer Immunotherapy

In recent years, there has been a considerable interest in the development of immunotherapeutic approaches for treating cancers, including strategies for inducing antigen-specific cytotoxic T cells (CTLs) capable of killing tumour cells in situ. These approaches include both the active induction of CTLs by vaccination of tumour bearing patients, and the ex vivo expansion of tumour-specific CTLs for adoptive cellular transfer. One promising approach has been through the generation of hybrid cells, formed by fusion of professional antigen presenting cells (

Cancer Vaccines

Cancer Vaccines
  • Author : Adrian Bot,Mihail Obrocea,Francesco M. Marincola
  • Publisher : CRC Press
  • Release : 06 May 2015
GET THIS BOOK Cancer Vaccines

Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: From Research to Clinical Practice is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. Cancer Vaccines: From Research to Clinical Practice: Analyzes the most promising classes of investigational immunotherapies, integrating

Cancer Vaccines

Cancer Vaccines
  • Author : Adrian Bot,Mihail Obrocea
  • Publisher : CRC Press
  • Release : 30 August 2019
GET THIS BOOK Cancer Vaccines

Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. Cancer Vaccines: Challenges and Opportunities in Translation: Critically analyzes the most promising classes of investigational immunotherapies,

Novel Approaches and Strategies for Biologics Vaccines and Cancer Therapies

Novel Approaches and Strategies for Biologics  Vaccines and Cancer Therapies
  • Author : Manmohan Singh,Maya Salnikova
  • Publisher : Academic Press
  • Release : 30 December 2014
GET THIS BOOK Novel Approaches and Strategies for Biologics Vaccines and Cancer Therapies

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies takes a look at the current strategies, successes and challenges involved with the development of novel formulations of biologics, vaccines and cancer therapy. This thorough reference on the latest trends in the development of diverse modalities will appeal to a broad community of scientists, students and clinicians. Written by leading authors across academia and industry, this book covers important topics such as unique drug delivery devices, non-parenteral delivery trends, novel

Immunotherapy of Cancer

Immunotherapy of Cancer
  • Author : Yoshiyuki Yamaguchi
  • Publisher : Springer
  • Release : 22 February 2016
GET THIS BOOK Immunotherapy of Cancer

This timely book, published just as cancer immunotherapy comes of age, summarizes the rationale, present status, and future perspective for cancer immunotherapy. Included are explanations of the constitution of the immune system and immunocheckpoints, the mechanism of antigen presentation and recognition, valuable modalities, clinical trials and guidance, personalization, and biomarkers, all of which are essential for understanding the success of cancer immunotherapy. This innovative therapy has been investigated worldwide as the fourth line of cancer treatment after the standard treatments

Tumor Immunology and Immunotherapy

Tumor Immunology and Immunotherapy
  • Author : Robert C. Rees
  • Publisher : Oxford University Press, USA
  • Release : 20 May 2014
GET THIS BOOK Tumor Immunology and Immunotherapy

Patients are beginning to benefit from antibody based, cellular and vaccine approaches that are effective against genetically diverse and therapy-resistance cancers. BCG immunotherapy is now being used as a first line treatment for human bladder cancer and the introduction of prophylactic vaccination against Hepatitis B and HPV cancers is starting to show positive results. Following recent FDA approval for a vaccination against prostate cancer, and optimistic results in clinical trials for a vaccine targeting cancer antigens in lung cancer, cancer